Shanghai - Delayed Quote CNY
CHINA NATIONAL MEDICINE (600511.SS)
28.99
+0.03
+(0.10%)
At close: April 30 at 3:00:03 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Guotao Tian | GM & Director | -- | -- | 1971 |
| Mr. Fei Chen | Chief Financial Officer | -- | -- | 1976 |
| Ms. Lichun Luo | General Counsel, Secretary of the Board & Chief Compliance Officer | -- | -- | 1982 |
| Ms. Tong Ye | Deputy General Manager | -- | -- | 1972 |
| Ms. Zhuo Yuan Xiao | Deputy General Manager | -- | -- | 1978 |
| Mr. Lei Tang | Deputy General Manager | -- | -- | 1972 |
| Ms. Zhang Ting | Deputy Secretary of the Party Committee | -- | -- | 1980 |
| Xinlei Li | Accounting Supervisor | -- | -- | -- |
CHINA NATIONAL MEDICINE
Floor 6-9, West Tower
7th Floor, Courtyard No. 8 West Binhe Road, Yongdingmen Dongcheng District
Beijing, 100077
China
- Sector:
- Healthcare
- Industry: Medical Distribution
- Full Time Employees:
- 3,104
Description
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
Corporate Governance
CHINA NATIONAL MEDICINE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 13, 2024 at 12:00 AM UTC
Ex-Dividend Date